Finance

Explore the landscape of Finance in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Finance to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Zhejiang Garden Biopharmaceutical and Guangzhou National Laboratory Form Joint Venture to Develop 25‑Hydroxycholesterol – A Prodrug‑Class Broad‑Spectrum Antiviral Program
CompanyDeals

Zhejiang Garden Biopharmaceutical and Guangzhou National Laboratory Form Joint Venture to Develop 25‑Hydroxycholesterol – A Prodrug‑Class Broad‑Spectrum Antiviral Program

Zhejiang Garden Biopharmaceutical Co., Ltd. (SHE: 300401) announced that it has signed the "25‑Hydroxycholesterol New Drug R&D Project Cooperation Agreement" with Guangzhou National Laboratory — establishing a joint venture to…

Adalvo and Jiangsu Sinopep‑Allsino Forge Strategic Partnership – Combining Peptide and Oligonucleotide Manufacturing Expertise with Commercial Reach Across 160+ Markets

Adalvo and Jiangsu Sinopep‑Allsino Forge Strategic Partnership – Combining Peptide and Oligonucleotide Manufacturing Expertise with Commercial Reach Across 160+ Markets

Wellington Zhaotai Therapies Signs USD 130 Million CAR‑T Sublicensing Agreement with BioOra – Advancing Cell Therapy Commercialization in International Markets Beyond Greater China and India

Wellington Zhaotai Therapies Signs USD 130 Million CAR‑T Sublicensing Agreement with BioOra – Advancing Cell Therapy Commercialization in International Markets Beyond Greater China and India

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Alebund Pharmaceuticals Completes Series C Financing to Advance Kidney Disease Pipelines
CompanyDeals

Alebund Pharmaceuticals Completes Series C Financing to Advance Kidney Disease Pipelines

Shengwei Kunteng Raises RMB 200 Million in Series A Financing for POCT Development
CompanyDeals

Shengwei Kunteng Raises RMB 200 Million in Series A Financing for POCT Development

Hangzhou Highlightll Pharma Completes Pre-Series C Financing Round
CompanyDeals

Hangzhou Highlightll Pharma Completes Pre-Series C Financing Round

Milestone Biotechnologies Secures Nearly 100 Million Yuan in Series A+ Funding
Company

Milestone Biotechnologies Secures Nearly 100 Million Yuan in Series A+ Funding

Prime Gene Therapeutics Secures Over RMB300 Million in Series B Financing
CompanyDeals

Prime Gene Therapeutics Secures Over RMB300 Million in Series B Financing

Maxvax Biotechnology Secures RMB 200 Million in Convertible Bonds Financing
CompanyDeals

Maxvax Biotechnology Secures RMB 200 Million in Convertible Bonds Financing

Shinva Medical Instrument to Acquire Stake in Wuhan Zhongzhi Biotechnologies for IVD Expansion
CompanyDeals

Shinva Medical Instrument to Acquire Stake in Wuhan Zhongzhi Biotechnologies for IVD Expansion

Reforgene Medicine Secures Hundreds of Millions in Financing for Gene Therapy Expansion
CompanyDeals

Reforgene Medicine Secures Hundreds of Millions in Financing for Gene Therapy Expansion

Show More